抄録
Hickman's dual lumen catheter (HDLC) was placed in 50 pediatric oncology patients for 56 times, and its usefulness was compared to a concurrent series of 42 patients receiving the Broviac catheter (BRO). All HDLCs were used for the purpose of medications, routine blood sampling and transfusions, and also used for total parenteral nutrition. Three HDLCs developed catheter-related sepsis (CRS) (5.4% /catheter, 0.51/1000 catheter days) while 4 BROs developed CRS (8.7% /catheter, 0.64/1000 catheter days). Complication rate with HDLC was not higher than with BRO. Patients with HDLC were completely relieved from the pain with puncturing peripheral vein for blood sampling and making infusion route. Based on the low incidence of complication, as well as on the improved patients' quality of life, HDLC can be safely utilized in the pediatric oncology patients.
